Literature DB >> 25343060

Current status in diagnosis and treatment of hereditary thrombotic thrombocytopenic purpura.

Hayley A Hanby1, X Long Zheng1.   

Abstract

Entities:  

Keywords:  ADAMTS13; Thrombotic thrombocytopenic purpura; arterial thrombosis; diagnosis; inherited or hereditary; therapy; von Willebrand factor

Year:  2014        PMID： 25343060      PMCID： PMC4204482          DOI： 10.4172/2161-1041.1000e108

Source DB:  PubMed          Journal:  Hereditary Genet        ISSN： 2161-1041


× No keyword cloud information.
  47 in total

Review 1.  Atypical hemolytic uremic syndrome.

Authors:  David Kavanagh; Timothy H J Goodship
Journal:  Curr Opin Hematol       Date:  2010-09       Impact factor: 3.284

2.  Inhibitory autoantibodies against ADAMTS-13 in patients with thrombotic thrombocytopenic purpura bind ADAMTS-13 protease and may accelerate its clearance in vivo.

Authors:  S G Shelat; P Smith; J Ai; X L Zheng
Journal:  J Thromb Haemost       Date:  2006-08       Impact factor: 5.824

3.  Eculizumab for atypical hemolytic-uremic syndrome.

Authors:  Jens Nürnberger; Thomas Philipp; Oliver Witzke; Anabelle Opazo Saez; Udo Vester; Hideo Andreas Baba; Andreas Kribben; Lothar Bernd Zimmerhackl; Andreas R Janecke; Mato Nagel; Michael Kirschfink
Journal:  N Engl J Med       Date:  2009-01-29       Impact factor: 91.245

Review 4.  Aetiology and pathogenesis of thrombotic thrombocytopenic purpura and haemolytic uraemic syndrome: the role of von Willebrand factor-cleaving protease.

Authors:  M Furlan; B Lämmle
Journal:  Best Pract Res Clin Haematol       Date:  2001-06       Impact factor: 3.020

5.  Improved survival in thrombotic thrombocytopenic purpura-hemolytic uremic syndrome. Clinical experience in 108 patients.

Authors:  W R Bell; H G Braine; P M Ness; T S Kickler
Journal:  N Engl J Med       Date:  1991-08-08       Impact factor: 91.245

6.  Inhibition of von Willebrand factor by ARC1779 in patients with acute thrombotic thrombocytopenic purpura.

Authors:  Petra Jilma-Stohlawetz; Monika E Gorczyca; Bernd Jilma; Jolanta Siller-Matula; James C Gilbert; Paul Knöbl
Journal:  Thromb Haemost       Date:  2010-12-21       Impact factor: 5.249

7.  Mutations in a member of the ADAMTS gene family cause thrombotic thrombocytopenic purpura.

Authors:  G G Levy; W C Nichols; E C Lian; T Foroud; J N McClintick; B M McGee; A Y Yang; D R Siemieniak; K R Stark; R Gruppo; R Sarode; S B Shurin; V Chandrasekaran; S P Stabler; H Sabio; E E Bouhassira; J D Upshaw; D Ginsburg; H M Tsai
Journal:  Nature       Date:  2001-10-04       Impact factor: 49.962

8.  Mutations and common polymorphisms in ADAMTS13 gene responsible for von Willebrand factor-cleaving protease activity.

Authors:  Koichi Kokame; Masanori Matsumoto; Kenji Soejima; Hideo Yagi; Hiromichi Ishizashi; Masahisa Funato; Hiroshi Tamai; Mutsuko Konno; Kei Kamide; Yuhei Kawano; Toshiyuki Miyata; Yoshihiro Fujimura
Journal:  Proc Natl Acad Sci U S A       Date:  2002-08-14       Impact factor: 11.205

9.  von Willebrand factor cleaving protease and ADAMTS13 mutations in childhood TTP.

Authors:  Reinhard Schneppenheim; Ulrich Budde; Florian Oyen; Dorothea Angerhaus; Volker Aumann; Elke Drewke; Wolf Hassenpflug; Johannes Häberle; Karim Kentouche; Elisabeth Kohne; Karin Kurnik; Dirk Mueller-Wiefel; Tobias Obser; René Santer; Karl-Walter Sykora
Journal:  Blood       Date:  2002-10-17       Impact factor: 22.113

10.  Anfibatide, a novel GPIb complex antagonist, inhibits platelet adhesion and thrombus formation in vitro and in vivo in murine models of thrombosis.

Authors:  Xi Lei; Adili Reheman; Yan Hou; Hui Zhou; Yiming Wang; Alexandra H Marshall; Chaofan Liang; Xiangrong Dai; Benjamin Xiaoyi Li; Karen Vanhoorelbeke; Heyu Ni
Journal:  Thromb Haemost       Date:  2013-10-31       Impact factor: 5.249
View more
  3 in total

1.  [A 2-day-old neonate with hyperbilirubinemia and thrombocytopenia].

Authors:  Chen Li; Zheng Chen; Ming-Yan Chen; Xiao-Lu Ma
Journal:  Zhongguo Dang Dai Er Ke Za Zhi       Date:  2019-12

2.  Diagnosis and management of acquired thrombotic thrombocytopenic purpura in southeast China: a single center experience of 60 cases.

Authors:  Xinping Zhou; Xingnong Ye; Yanling Ren; Chen Mei; Liya Ma; Jiansong Huang; Weilai Xu; Juying Wei; Li Ye; Wenyuan Mai; Wenbin Qian; Haitao Meng; Jie Jin; Hongyan Tong
Journal:  Front Med       Date:  2016-12-23       Impact factor: 4.592

3.  Patient Experience with Congenital (Hereditary) Thrombotic Thrombocytopenic Purpura: A Conceptual Framework of Symptoms and Impacts.

Authors:  Abiola O Oladapo; Diane Ito; Christopher Hibbard; Stephanie E Bean; Robert N Krupnick; Bruce M Ewenstein
Journal:  Patient       Date:  2019-10       Impact factor: 3.883
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.